No Stockholder Action Required at This Time REDWOOD CITY, Calif. — Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it has received an unsolicited, non-binding proposal from Omid Farokhzad, M.D., Seer’s Chair and Chief Executive Officer, to acquire all of the outstanding shares of Seer’s Class […]
AnalytiChem consolidates chemicals product expertise, innovation and heritage under one unified global brand AnalytiChem brings together Bernd Kraft, Chem-Lab and SCP Science under a unified global AnalytiChem product brand Eschborn, Germany — AnalytiChem, manufacturer of specialized chemicals, reagents, accredited standard, equipment and consumables, has announced that the brand transition of its chemical product ranges, currently […]
Seer’s particle-based proteomics IP withstands challenges in both Europe and the United States REDWOOD CITY, Calif. — Seer, Inc. (Nasdaq: SEER), a pioneer and trusted partner for deep, unbiased proteomic insights, today announced two significant developments that reinforce the strength of the intellectual property portfolio protecting its proprietary nanoparticle protein enrichment technology. These milestones underscore Seer’s […]
Investment brings Pictor’s total capital raised to approximately $30 million, supporting expanded U.S. and international commercialization efforts CARLSBAD, Calif. — Pictor Holdings Inc., a global targeted proteomic platform company headquartered in Carlsbad, California, today announced the closing of a $7.5 million bridge round of growth capital. The financing was supported by existing investors and will be […]
The Atlas® system provides spectroscopic analysis in less than one minute, offering the potential for more rapid time to results and greater process understanding Eliminates the need for offline, labor-intensive laboratory-based methods using hazardous chemicals BILLERICA, Mass. — Nirrin Technologies, a developer of analytical tools designed to transform bioprocess analytics, today announced that Hyaltech, a […]
LA JOLLA, CA — AAA Biotech, a supplier of high-quality research reagents for life science applications, today announced the expansion of its global authorized distributor network aimed at improving access to antibodies, recombinant proteins, and ELISA kits for researchers across key international markets. This expansion strengthens the company’s commitment to supporting biomedical research by ensuring faster […]
Genovis AB today announces the commercial launch of AlligBAITOR™, a novel immunoglobulin-binding protein that expands the company’s offering in advanced protein analysis. The product enables capture of all major antibody isotypes and uniquely facilitates the release of antigens from antibody-antigen complexes under native conditions. Together with the high-performance enzymes added through the recent acquisition of […]
Accelerating Entry into the Middle East Energy Transition Market HORIBA, Ltd. (President: Masayuki Adachi; hereinafter “HORIBA”) announced on February 13, 2026, the establishment of HORIBA Middle East Limited in Abu Dhabi. The new company marks HORIBA’s first presence in the Middle East and will be located in Masdar City, a pioneering sustainable urban community and […]
Purchase price of US$73 per share in cash represents an enterprise value of US$11.3 billion (EUR 9.9 billion). Darmstadt, Germany Purchase price of US$73 per share in cash represents an enterprise value of US$11.3 billion (EUR 9.9 billion) Proposed acquisition expected to be immediately accretive to sales growth and EBITDA pre margin post-closing, and EPS […]
IMU’s AI platform unlocks unprecedented immune insights for cancer and other diseases, measuring 100M+ data points from a single blood sample, analyzed in real time. Waters Biosciences’ technologies, including BD FACSDiscover™ and BD Rhapsody™ Instruments, will be used with IMU’s AI analytics in research to deliver deeper, population-level disease insights. Partnership supports IMU’s expansion of […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
